1 |
CHEN D S, MELLMAN I. Elements of cancer immunity and the cancer-immune set point[J]. Nature, 2017, 541(7637): 321-330.
|
2 |
江魁.人源化小鼠模型在肿瘤免疫治疗中的应用进展[J].国际生物制品学杂志, 2020, 43(5): 229-233.
|
3 |
DE L A R P, GUIL-LUNA S, DECAUDIN D, et al.. Humanized mice for the study of immuno-oncology[J].Trends Immunol., 2018, 39(9): 748-763.
|
4 |
PARK N, PANDEY K, CHANG S K, et al.. Preclinical platform for long-term evaluation of immuno-oncology drugs using hCD34+ humanized mouse model[J/OL]. J. Immunol. Ther. Cancer, 2020, 8(2): e001513[2022-02-10]. .
|
5 |
郭文文,乔天运,张彩勤,等.免疫系统人源化小鼠模型的构建及其在肿瘤治疗研究中的应用[J].中国比较医学杂志, 2019, 29(11): 98-104.
|
6 |
GUO W, ZHANG C, QIAO T, et al.. Strategies for the construction of mouse models with humanized immune system and evaluation of tumor immune checkpoint inhibitor therapy[J]. Front. Oncol., 2021, 11: 1-11.
|
7 |
OHNO Y, OHSHIMA S, MIYAMOTO A, et al.. HER2-antigen-specific humoral immune response in breast cancer lymphocytes transplanted in hu-PBL hIL-4 NOG mice[J/OL]. Sci. Rep., 2021, 11(1): 12798[2022-04-08]. .
|
8 |
PYO K H, KIM J H, LEE J M, et al.. Promising preclinical platform for evaluation of immuno-oncology drugs using Hu-PBL-NSG lung cancer models[J]. Lung Cancer, 2019, 127: 12-121.
|
9 |
HAN Y, LIU C, LI G, et al.. Antitumor effects and persistence of a novel HER2 CAR T cells directed to gastric cancer in preclinical models[J]. Am. J. Cancer Res., 2018, 8(1): 106-119.
|
10 |
ZHENG B, REN T, HUANG Y, et al.. PD-1 axis expression in musculoskeletal tumors and antitumor effect of nivolumab in osteosarcoma model of humanized mouse[J/OL]. J. Hematol. Oncol., 2018, 11(1):16[2022-03-01]. .
|
11 |
LIN S, HUANG G, CHENG L, et al.. Establishment of peripheral blood mononuclear cell-derived humanized lung cancer mouse models for studying efficacy of PD-L1/PD-1 targeted immunotherapy[J]. MAbs, 2018, 10(8): 1301-1311.
|
12 |
陈冰,刘昊川,李龙云,等.人源化小鼠模型构建和应用的研究进展[J].吉林大学学报(医学版), 2018, 44(3): 667-674.
|
13 |
NOTTA F, DOULATOV S, DICK J E. Engraftment of human hematopoietic stem cells is more efficient in female NOD/SCID/IL-2Rgc-null recipients[J]. Blood, 2010, 115(18): 3704-3707.
|
14 |
VOLK V, SCHNEIDER A, SPINELI L M, et al.. The gender gap: discrepant human T-cell reconstitution after cord blood stem cell transplantation in humanized female and male mice[J]. Bone Marrow Transpl., 2016, 51(4): 596-597.
|
15 |
VOLK V, REPPAS A I, ROBERT P A, et al.. Multidimensional analysis integrating human T-cell signatures in lymphatic tissues with sex of humanized mice for prediction of responses after dendritic cell immunization[J/OL]. Front. immunol, 2017, 8: 1709[2022-01-25]. .
|
16 |
郭文文.免疫系统人源化小鼠模型的构建及应用[D].延安: 延安大学, 2021.
|
17 |
王岩石,田志刚.免疫系统人源化小鼠的构建及其应用进展[J].中国免疫学杂志, 2016, 32(3): 289-298.
|
18 |
WANG M, YAO LC, CHENG M, et al.. Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy[J]. FASEB J., 2018, 32(3): 1537-1549.
|
19 |
RIOS-DORIA J, STEVENS C, MADDAGE C, et al.. Characterization of human cancer xenografts in humanized mice[J/OL]. J. Immunother. Cancer, 2020,8:e000416[2022-04-28]. .
|
20 |
罗宝花,刘晓秋,雷静玉,等.胰腺癌免疫系统人源化小鼠模型的构建及评估[J].中国实验动物学报,2022,30(2):161-168.
|